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The vestibulo-sympathetic reflex (VSR) actively modulates blood pressure during
changes in posture. This reflex allows humans to stand up and quadrupeds to rear or
climb without a precipitous decline in cerebral perfusion. The VSR pathway conveys
signals from the vestibular end organs to the caudal vestibular nuclei. These cells,
in turn, project to pre-sympathetic neurons in the rostral and caudal ventrolateral
medulla (RVLM and CVLM, respectively). The present study assessed glutamate-
and GABA-related immunofluorescence associated with central vestibular neurons of
the VSR pathway in rats. Retrograde FluoroGold tract tracing was used to label
vestibular neurons with projections to RVLM or CVLM, and sinusoidal galvanic vestibular
stimulation (GVS) was employed to activate these pathways. Central vestibular neurons
of the VSR were identified by co-localization of FluoroGold and cFos protein, which
accumulates in some vestibular neurons following galvanic stimulation. Triple-label
immunofluorescence was used to co-localize glutamate- or GABA- labeling in the
identified VSR pathway neurons. Most activated projection neurons displayed intense
glutamate immunofluorescence, suggestive of glutamatergic neurotransmission. To
support this, anterograde tracer was injected into the caudal vestibular nuclei. Vestibular
axons and terminals in RVLM and CVLM co-localized the anterograde tracer and
vesicular glutamate transporter-2 signals. Other retrogradely-labeled cFos-positive
neurons displayed intense GABA immunofluorescence. VSR pathway neurons of both
phenotypes were present in the caudal medial and spinal vestibular nuclei, and projected
to both RVLM and CVLM. As a group, however, triple-labeled vestibular cells with
intense glutamate immunofluorescence were located more rostrally in the vestibular
nuclei than the GABAergic neurons. Only the GABAergic VSR pathway neurons showed
a target preference, projecting predominantly to CVLM. These data provide the first
demonstration of two disparate chemoanatomic VSR pathways.
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Frontiers in Neuroanatomy | www.frontiersin.org 1 February 2016 | Volume 10 | Article 7
Holstein et al. Glutamate and GABA in Vestibulo-Sympathetic Pathway Neurons
INTRODUCTION
Homeostatic control of blood pressure is mediated by the
baroreflex, a highly effective closed-loop negative feedback
pathway responsible for maintaining stable blood pressure (Hall,
2016). The baroreflex utilizes inputs from carotid and aortic
baroreceptors that are conveyed to the solitary nucleus (Spyer,
1981) and from there to the caudal ventrolateral medulla
(CVLM). The CVLM sends both excitatory and inhibitory
projections to the rostral ventrolateral medulla (RVLM), which
in turn provides critical descending input to the preganglionic
neurons in the spinal cord that control sympathetic nerve
activity including the innervation of vascular smooth muscle
(Blessing, 1988; Holstege, 1989; Guyenet, 1990; Stocker et al.,
1997; Chan and Sawchenko, 1998; Pilowsky and Goodchild,
2002; Dampney et al., 2003; Schreihofer et al., 2005; Heesch
et al., 2006). The baroreflex pathway is polysynaptic, poorly
myelinated, has a relatively long latency and is solely reactive,
modulating vasoconstriction and heart rate in response to a
prior cardiovascular vicissitude (Yates et al., 2014a) such as
a drop in blood pressure. More direct and rapid modulation
of blood pressure in response to head movements and other
postural adjustments is achieved through interactions between
vestibular end organ-activated neurons in the vestibular nuclei
and presympathetic brainstem cell groups, including RVLM and
CVLM (Yates and Bronstein, 2005). These vestibulo-sympathetic
reflex (VSR) pathways provide a proactive mechanism for
initiating blood redistribution in the body during movement
or changes in posture in order to assure consistent cerebral
perfusion (Yates, 1996; Kerman et al., 2000b) regardless of head
position (Yates and Miller, 1994; Woodring et al., 1997; Balaban
and Yates, 2004; Abe et al., 2009; Nakamura et al., 2009).
The first experimental demonstration of the VSR was
published in 1974 (Doba and Reis, 1974). That study reported
blood pressure responses to whole body nose-up tilt before
and after bilateral vestibular nerve section in cats. Since blood
pressure dropped more precipitously after the deafferentation,
the investigators concluded that the lesion caused orthostatic
intolerance, suggesting a role for the vestibular system in blood
pressure modulation. Since then, studies in several experimental
models, including cats, rabbits and rats, utilizing a variety
of physiological vestibular stimuli such as caloric stimulation,
head rotation, whole body tilt, horizontal and vertical linear
acceleration, centrifugation, off-vertical-axis rotation, Ferris
Wheel rotation and spaceflight have contributed to our
understanding of the VSR (Kaufman et al., 1992; Marshburn
et al., 1997; Gustave Dit Duflo et al., 2000; Saxon et al., 2001; Chen
et al., 2003; Fuller et al., 2004; Kaufman, 2005; Zhang et al., 2005;
Lai et al., 2006, 2008; Tse et al., 2008; Abe et al., 2009; Baizer et al.,
2010; Cai et al., 2010). Additional information has been gleaned
from studies utilizing electrical stimulation of the vestibular end
organs and/or nerve, including galvanic vestibular stimulation
(GVS).
Sinusoidally modulated GVS (sGVS) involves the passage
of low frequency direct current (1–4 mA) across the labyrinths
delivered through electrodes inserted under the skin over
the mastoid processes (Bent et al., 2006; Curthoys, 2010;
Hammam et al., 2011). The stimulus is experimentally
advantageous for studies of the VSR because it is minimally
invasive, does not cause shifts in body fluids, and is unlikely
to activate neck proprioceptors or non-vestibular abdominal
graviceptors (Yates et al., 2014a). Stimulation at the cathode
specifically activates the vestibular nerve fibers, particularly
those with irregular spontaneous discharge rates (Goldberg et al.,
1984; Minor and Goldberg, 1991), while afferents at the anode
are inhibited (Fitzpatrick and Day, 2004). S-GVS appears to
exert a more robust and prolonged effect on the otolith system
than on the semicircular canal pathways, and is a highly effective
stimulus for modulating sympathetic nerve activity and blood
pressure in humans and experimental animals (Courjon et al.,
1987; Ray et al., 1998; Abe et al., 2008b, 2009; Cohen et al., 2011b;
Yates et al., 2014a).
Despite a large body of research demonstrating the existence
and functionality of the VSR, relatively little is known about
the specific connectivity and chemical anatomy of neurons
involved in the vestibular modulation of blood pressure. Our
laboratory has previously demonstrated that there is a direct
projection from the caudal vestibular nuclei to RVLM and
CVLM (Holstein et al., 2011). This work also documented
the cytology of vestibular neurons participating in these
pathways, and the morphology of their axons and terminals.
Subsequently, we utilized sGVS to modulate blood pressure,
and then visualized cFos protein in vestibular neurons activated
by the stimulation (Holstein et al., 2012). We observed that
sGVS-activated neurons were present throughout the rostro-
caudal extent of the vestibular nuclear complex, and were
particularly concentrated in parts of the spinal (SpVN),
medial (MVN) and superior vestibular nuclei. Based on a
qualitative assessment, it was estimated that approximately
one third of the cFos-positive vestibular neurons showed
intense glutamate immunofluorescence. However, vestibular
neurons activated by GVS and containing the immediate
early gene cfos could participate in one or more of the
vestibular effector pathways that are particularly sensitive to
otolith stimulation, including otolith-ocular reflexes, ascending
vestibulo-autonomic pathways to limbic-related regions, as
well as the descending projections to RVLM and CVLM
involved in homeostatic functions. In order to identify the
vestibular neurons specifically involved in this latter pathway,
we combined cFos detection of sGVS-activated neurons with
retrograde tract tracing from RVLM or CVLM, and mapped
the locations of the double-labeled activated projection neurons
of the VSR (Holstein et al., 2014). These maps indicated
that VSR neurons projecting to RVLM and CVLM are only
present in the caudal half of MVN and SpVN, a region
that is significantly more discrete than the vestibular areas
identified by cFos localization alone. The present study was
conducted to identify glutamate andGABA immunofluorescence
associated with the activated projection neurons contributing
to the descending vestibulo-autonomic projection, as a first
step toward specifying the chemoanatomic phenotype of VSR
pathway neurons. These two amino acids were selected for this
study because of their well-documented roles in other vestibular
efferent pathways.
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MATERIALS AND METHODS
All experiments were conducted in accordance with the NRC
Guide for the Care and Use of Laboratory Animals (8th Edition,
2011), and were approved by the Institutional Care and
Use Committee of the Icahn School of Medicine at Mount
Sinai, NY, USA. Data were obtained from 23 adult male
Long-Evans rats (Harlan Laboratories, MA, USA) weighing
350–450 g. Ten of these animals received injections of the
retrograde tracer Fluorogold (Fluorochrome, LLC, Denver,
CO, USA) in RVLM, seven had FluoroGold injections in
CVLM, and three received injections of the anterograde tracer
Phaseolus vulgaris leucoagglutinin (Pha-L; Vector Labs; Cat.
#L-1110; Burlingame, CA, USA) in the caudal vestibular nuclear
complex. Sections from three additional rats in which the
retrograde tracer injections spanned parts of both RVLM
and CVLM were used exclusively for corroborative qualitative
observations.
Retrograde Tracer Injections
FluoroGold was utilized because of its high sensitivity, low
probability of uptake by fibers of passage and lack of
concomitant anterograde transport (Raju and Smith, 2006;
Schofield, 2008). Rats were anesthetized with isoflurane (4%
induction, 2% maintenance), shaved and placed in a computer-
assisted stereotaxic frame (Leica Angle Two, Leica Microsystems,
St. Louis, MO, USA). Homeothermy was maintained by resting
the animals on a homeothermic pad regulated by the feedback
from a rectal thermometer. Ophthalmic ointment was used
to keep the eyes moist, and one dose of the analgesic
Buprenex (Reckitt Benckiser Pharmaceuticals; Richmond, VA,
USA) was administered preemptively (0.05 mg/kg, SQ). After
draping the animal for aseptic surgery, the head and neck
were disinfected with Povidone and a midline incision was
made from the top of the skull to the C1 vertebra. The
atlanto-occipital membrane was exposed by blunt dissection
and retraction of the neck muscles. A glass pipette (tip OD
∼20–25 µm) filled with 2% FluoroGold dissolved in saline
was mounted on the Angle Two dorsoventral drive (DV)
tilted 45◦ over the horizontal plane. The target coordinates
for CVLM (ML: ±2.2; AP: −12.80; DV: −10.0) or RVLM
(ML: ±2.34; AP: −12.24; DV: −10.21; Paxinos and Watson,
2009) were entered in the computer, and the pipette tip
was positioned at Bregma. The Angle Two AP and ML
drives were then adjusted, and the pipette was advanced
under computer guidance toward the brainstem target via
a small burr hole (∼2 mm dia.) drilled slightly above the
atlanto-occipital membrane at ML ± 2.3 mm. The tracer
was iontophoresed at +5 µA for 10 min (7 s on, 7 s
off). The pipette was left in place for 2–3 min after the
conclusion of the iontophoresis, and then slowly withdrawn.
The neck muscles were sutured with interrupted stitches
and the skin was closed with surgical clips. Rats received
3–4 ml of sterile saline SQ at the end of the procedure.
Analgesics were administered twice daily for 3 days after surgery
(Buprenex; 0.05 mg/kg; SQ). The animals were allowed to
recover for 10–14 days before the terminal experiment was
performed.
Anterograde Tracer Injections
The anesthesia and surgical preparation for these injections were
the same as those described above. A small amount of occipital
bone was removed with fine rongeurs to allow the glass pipette
to reach the vestibular nuclei from a dorsal approach at an
angle of 22◦ from the horizontal plane. The glass pipette (tip
OD ∼10–15 µm) was initially zeroed on the obex (calamus
scriptorius) and then moved 0.45 mm caudally and 0.8–1.0 mm
laterally. After raising 1.4–1.5 mm (off-vertical movement), the
pipette was advanced 2.5–2.8 mm into the caudal vestibular
nuclei. Rats received a 15 min iontophoretic injection (7 s on/7 s
off; 5 µA) of 2% Pha-L dissolved in 0.1 M phosphate buffer (PB;
pH 8.0). The pipette was withdrawn 2–5 min after the injection.
The incision closure and postoperative treatment were identical
to that described above. The animals were allowed to recover for
10–14 days before the terminal experiment was performed.
sGVS
Animals anesthetized with isoflurane (4% induction; 2%
maintenance) were kept on a homeothermic pad. Ag/AgCl
needle electrodes (BAK) connected to a computer-controlled
current stimulator (Cohen et al., 2011a) were inserted bilaterally
under the skin over the mastoid processes. An individual sGVS
stimulus comprised five cycles of binaural current (2 mA,
0.025 Hz). This stimulus was repeated five times with 3 min
between repetitions. Rats were then allowed to recover from the
anesthesia, and were euthanized 90 min after the cessation of the
last sGVS stimulus.
Tissue Harvesting and Processing
Perfusion, Fixation and Tissue Sectioning
Rats anesthetized with isoflurane (as above) were perfused
transcardially 90 min after the sGVS stimulation, a time point
of peak c-Fos protein accumulation in most experimental
paradigms (Kovács, 2008; Durchdewald et al., 2009). In addition,
our previous studies demonstrated that a time interval of
90 min after sGVS or tilt stimulation and euthanasia is sufficient
for robust cFos protein accumulation in vestibular neurons
(Holstein et al., 2012, 2014). The initial perfusion with 100 ml
of 37◦C 10 mM phosphate buffered saline (PBS) was followed by
500 ml of 4% paraformaldehyde/0.2% glutaraldehyde fixative in
0.1M PB (pH 7.4) at room temperature. Brains were harvested
immediately after perfusion, cut into blocks using an adult rat
brain coronal matrix (Ted Pella, Inc.; Redding, CA, USA), and
stored at 4◦C in PBS with 0.02% NaN3. A vibrating microtome
was used to cut the block containing the vestibular nuclear
complex and ventrolateral medullary region into 50 µm serial
sections. These sections (∼120 per animal) were stored in PBS
containing 0.02% NaN3 at 4◦C.
Anatomical Localization
The locations of the four principal vestibular nuclei were
determined in each tissue section by comparing the anatomical
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landmarks on the dorsal aspect of the tissue with a standard
stereotaxic atlas (Paxinos and Watson, 2005). Although this
atlas was made using sections from Wistar rats, and the present
study utilized the Long-Evans strain, we did not observe any
significant neuroanatomical differences in the caudal vestibular
nuclei, RVLM or CVLM of the two strains. It is worth noting that
theAngle Two injection guidance system also utilizes Paxinos and
Watson coordinate space, and our success rate in targeting the
structures of interest is∼80%. This suggests that the Paxinos and
Watson stereotaxic atlas coordinates are sufficient for the level of
resolution relevant to this study.
Similarly, the boundaries of RVLM and CVLM were
determined by comparing the structures on the ventral aspect
of the tissue sections with published maps and atlases of
those regions (Paxinos and Watson, 2005, 2009; Card et al.,
2006; Bourassa et al., 2009; Goodchild and Moon, 2009). Based
on the most conservative estimates from these maps, RVLM
was localized to a 1 mm rostrocaudal region extending from
approximately 11.8–12.8 mm caudal to Bregma. The other
dimensions of RVLM were determined by a triangle with the
ventral aspect of the medulla 1.4 and 2.2 mm lateral to the
midline as two of the points and nucleus ambiguus (pars
compacta) at the apex. The CVLM region, located 12.8–13.6 mm
caudal to Bregma, was similarly defined according to anatomical
coordinates. Both regions correspond well with functional and
physiological maps of RVLM and CVLM (Goodchild and Moon,
2009). The locations of RVLM and CVLM were further verified
in our experimental animals using tyrosine hydroxylase and
GABA immunostaining of representative sections through these
regions from the three Long-Evans rats with Pha-L injections in
the vestibular nuclei, as previous demonstrated (Holstein et al.,
2011).
Primary Antibodies
Individual tissue sections were immunostained using one of
the following primary antibody combinations: (1) anti-cFos,
-FluoroGold and -glutamate; (2) anti-cFos, -FluoroGold and
-GABA; (3) anti-Pha-L, -glutamate and -vesicular glutamate
transporter (VGluT)-1; (4) anti-Pha-L, -glutamate and
-VGluT-2; and (5) anti-Pha-L, -glutamate and -VGluT-3.
Antibody sources and descriptions are shown in Table 1. The
rationale for their use, staining protocols, and controls are
described below.
We previously evaluated several commercial antibodies
against c-Fos including a rabbit polyclonal antiserum directly
conjugated with AlexaFluor 488 (Santa Cruz Biotechnology,
Cat. # sc-253 AF488) and two unconjugated rabbit polyclonal
antisera (Santa Cruz Biotechnology, Cat.# sc-253; Calbiochem,
Cat.# PC38; Holstein et al., 2014). Although the three reagents
stained the same vestibular regions and cell types, the unlabeled
polyclonal sera provided more robust labeling in multiple
label immunofluorescence staining experiments. To assess non-
specific staining, control tissue sections were exposed to a
mixture of the rabbit polyclonal antibody preabsorbed with
blocking peptide (Santa Cruz Biotechnology; Cat.# sc-253P); no
immunolabeling was apparent in these sections. Previous studies
in our laboratory have demonstrated that cFos-peroxidase
immunolabeling in mock (non)-sGVS-stimulated rats comprises
less than three neurons/vestibular region/tissue section (Holstein
et al., 2012). Given the higher sensitivity of the peroxidase
labeling system, fewer non-stimulation-dependent cFos-positive
vestibular neurons are likely to be obtained using the
immunofluorescence approach taken in the present study.
The FluoroGold tracer was amplified by immunostaining
with a rabbit polyclonal anti-FluoroGold serum (Millipore; Cat.#
AB153). Both the c-Fos and FluoroGold primary antibodies
provided staining of the same vestibular regions and cells
observed previously (Holstein et al., 2011, 2012, 2014). Pha-L
was visualized using a polyclonal rabbit anti-Pha-L (E + L)
serum (Vector Labs). Bothmonoclonal and polyclonal antibodies
against VGluTs-1 and -2 were used; VGluT-3 was identified
using a rat monoclonal antibody only.
The GABA and glutamate antibodies are both mouse IgG1
monoclonals produced in our laboratory. Full descriptions of
the production, characterization and specificity of the two
antibodies were previously published (Holstein et al., 2004).
Additional assays verified that glutamate can be fixed in situ by
glutaraldehyde and that the fixed glutamate can specifically be
recognized by the monoclonal antibody (MAb 215B2; Holstein
et al., 2011).
Immunoperoxidase/Diaminobenzidine Staining
To identify the FluoroGold injection sites in the ventrolateral
medulla or the Pha-L injection sites in the caudal VNC, series’
of vibratome sections from each injected rat were incubated in
blocking buffer (PBS with 10% normal goat serum, 0.02% NaN3
and 0.1% Triton X-100) for 4–6 h or overnight, and then in
anti-FluoroGold antibody (1:5000 in blocking buffer) or anti-
Pha-L antibody (1:1000 in blocking buffer) for 12–18 h. After
thorough rinsing (six changes of PBS over 4–6 h), the free-
floating sections were incubated in peroxidase-conjugated goat
anti-rabbit secondary antibody (Jackson ImmunoResearch Cat. #
111-035-144; 1:2000 in blocking buffer without NaN3) overnight.
Sections were then rinsed in PBS (six changes over 2 h) and
incubated in diaminobenzidine (DAB; 0.5 mg/ml; Sigma D-5905;
St. Louis, MO, USA) diluted in 0.1M Tris buffer (pH 7.6) with
0.01% H2O2 for 5–10 min at room temperature. The reaction
was stopped by repeated PBS rinses. Concomitantly processed
control sections were treated as above, save for the omission of
primary and/or secondary antibody.
Immunofluorescence
Tissue sections were processed for three-channel
immunofluorescence detection of combinations of primary
and secondary reagents. Some sections were also stained with
DAPI (ThermoFisher Scientific; Cat # D-1306) to visualize the
location and approximate size range of cell nuclei. Since both the
cFos and FluoroGold primary antibodies were raised in rabbit,
the studies were performed by sequential application of primary
and secondary antibodies. Briefly: (i) sections were exposed
initially to rabbit anti-cFos primary followed by fluorochrome-
labeled (e.g., AlexaFluor 488) Fab fragment of a goat anti-rabbit
IgG secondary; (ii) unreacted sites on the anti-cFos were blocked
using a high concentration of unlabeled Fab fragment of goat
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TABLE 1 | Primary antibodies used in this study.
Antigen Host and Type Immunogen Source Working dilutions
FluoroGold Rabbit polyclonal Fluorogold Millipore; Cat. # AB153 1:400 (IMF); 1:5000 (DAB)
c-Fos Rabbit polyclonal A peptide mapping within an internal
region of human c-Fos
Santa Cruz Biotech; Cat. # Sc-253 1:500
Pha-L Rabbit polyclonal Pha-L (E + L), unconjugated Vector Labs; Cat#AS-2300 1:1000 (DAB); 1:100 (IMF)
Glutamate Mouse monoclonal IgG1 Glutamate-BSA Our laboratory; Clone 215B2
Hybridoma supernatant
1:5
GABA Mouse monoclonal IgG1 GABA-BSA Our laboratory; Clone C6B6
Hybridoma supernatant
1:20
VGluT-1 Mouse monoclonal IgG1 Fusion protein amino acids
493-560 (cytoplasmic C-terminus) of
rat VGlut1
NeuroMab Antibodies; Cat # 75-066 1:10
VGluT-1 Rabbit polyclonal Fusion protein amino acids 493-560 Synaptic Systems; Cat #135-302 1:500
VGluT-2 Mouse monoclonal IgG1 Fusion protein amino acids 501-582 NeuroMab Antibodies; Cat # 75-067 1:10
VGluT-2 Rabbit polyclonal Strep-Tagr fusion protein of rat
VGLUT 2 (amino acids 510-582)
Synaptic Systems; Cat #135-402 1:800
VGluT-3 Rat monoclonal; IgG1 Fusion protein amino acids 546-588 NeuroMab Antibodies; Cat # 75-073 1:10
anti-rabbit secondary antibody; and (iii) stained sections were
exposed to rabbit anti-FluoroGold followed by goat anti-rabbit
IgG secondary antibody tagged with a different fluorochrome
(e.g., AlexaFluor 568). The sequence of primaries was alternated
across staining experiments. A detailed description of the
procedure is provided below.
All steps were performed at room temperature with agitation
on an orbital shaker. Free-floating sections were blocked for
3–6 h in blocking buffer; incubated for 12–18 h in rabbit anti-
c-Fos primary antibody (1:500 in blocking buffer); washed for
4–8 h with multiple changes of PBS; incubated for 12–18 h in
AlexaFluor- or DyLite-conjugated goat anti-rabbit IgG (H + L)
antibody Fab fragment (8 µg/ml in blocking buffer; Jackson
ImmunoResearch); washed for 4–8 h in multiple changes
of PBS; fixed briefly (10 min) with 2% paraformaldehyde;
washed again; exposed 12–18 h to unlabeled Fab fragment
goat anti-rabbit IgG (20 µg/ml in blocking buffer; Jackson
ImmunoResearch); washed; treated 12–18 h with a mixture
of rabbit anti-FluoroGold primary antibody (1:400 in blocking
buffer) and mouse anti-glutamate (1:10 hybridoma supernatant
in blocking buffer); washed; and treated with AlexaFluor-
conjugated goat anti-rabbit IgG (H + L; 1:400 in blocking buffer;
Invitrogen) and AlexaFluor-conjugated goat anti-mouse IgG
(H + L; 1:300 in blocking buffer; Invitrogen). Following this
staining, sections were incubated in DAPI solution (300 nM
in PBS) for 30 min. After final washes, all sections were
mounted on glass slides and coverslipped using Prolong Gold
AntiFade mounting medium (Invitrogen). Since we have found
varying degrees of sensitivity among secondary antibodies,
several different secondary antibodies and several alternative
fluorochromes (in different sections) were used to detect each
primary antibody.
All experiments included the following controls: (1) tissue
sections labeled with multiple secondary antibodies but only one
primary antibody; (2) sections labeled with multiple secondary
antibodies but no primary antibody; and (3) sections treated
with the blocking and rinsing steps, but no antibody incubations.
All data for this study derived from experiments in which
each secondary antibody bound exclusively to its appropriate
primary antibody and there was no binding to the inappropriate
primary reagents. In addition, all of the immunofluorescence-
stained sections contained profiles that were stained by only
one of the colors in the specimen’s secondaries mixture. This
provided further assurance within each individual section that
only one secondary antibody bound to each primary antibody
and therefore that secondary antibody cross-reactivity was
insignificant.
Microscopy and Image Preparation
Sections were examined and images were acquired with a Zeiss
Axioplan2 microscope equipped with structured illumination
(ApoTome). Regions of interest were recorded with 10× or 20×
objectives for cell body analysis, and 40× or 100× objectives
for boutons. With our equipment, these yield image pixel sizes
of 0.64, 0.32, 0.16, and 0.07 µm, respectively. Excitation and
exposure conditions were kept constant within each image
recording session.
Each session included images of intensity-calibrated
fluorescent beads (InSpeck, Invitrogen), which allowed the
intensity values in the images to be transformed to a scale
based on the beads and therefore reasonably independent of
image recording conditions. This strategy is advantageous
because it permits comparisons of fluorescence intensities
across specimens, experiments and imaging sessions. Using this
approach, the level of fluorescence designated as ‘‘intense’’ was
set at 75% of maximal fluorescence intensity.
Immunofluorescence was recorded using multichannel
z-stacks (gray scale). The images were analyzed by assessing
the immunofluorescence present in each gray scale optical slice
of each single channel separately. Antibody co-localization
was initially screened using maximum intensity projections
(MIP) through the z-stacks and both x-z and y-z sideviews
of pseudocolored image stacks constructed using the Zeiss
Apotome software. Co-localization was then verified by
comparing the gray scale immunofluorescence present in each
individual channel within the same optical slice. Volocity, ImageJ
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and AxioVision were used to generate z-axis MIPs of whole
stacks or selected subsets of optical sections for presentation
figures. Images were prepared (cropped, sized, colored, labeled,
annotated) using Adobe Photoshop and Illustrator CS6.
Adjustments of brightness and contrast were performed using
the Photoshop Levels and Curves tools applied to all parts of
each image. The details of our image processing strategy for
figure preparation are published in Holstein et al. (2014).
Atlas Data
Anatomical landmarks identified in all stained sections were
used to estimate Bregma levels according to a standard rat
brain stereotaxic atlas (Paxinos and Watson, 2009). As noted
above, there were no significant differences in the caudal
vestibular nuclei, RVLM or CVLM of the Wister-based atlas and
our Long-Evans tissue sections. DAB stained sections used to
identify the FluoroGold and Pha-L injection sites were imaged,
and the location of the injection site and tracer diffusion
penumbra in each animal were plotted manually on brainstem
drawings referenced to the atlas sections. Similarly, all cFos-
and FluoroGold-immunofluorescent double-labeled vestibular
neurons were imaged and mapped. Data from the ten rats
with FluoroGold injections within RVLM were pooled, as were
the data from the seven rats with FluoroGold injections in
CVLM.
Quantitation
Sections from the entire rostro-caudal extent of the vestibular
nuclear complex were examined and fields containing cells
positive for FluoroGold, cFos, and glutamate or GABA were
recorded using 10× or 20× objective lenses. All FluoroGold-
positive/cFos-positive cells were counted in images from
immunofluorescence-stained sections containing at least one
double-labeled vestibular neuron. Sections from the same animal
were separated by at least 100 µm to avoid counting the same
neuron twice.
Statistics
Data were analyzed using Microsoft Excel. One- and two-way
contingency tables of pooled raw counts and congruent tables of
expected values were constructed and chi-square analyses were
performed using the Excel function chisq.test. Tests were not
performed where any expected value was<5. Since comparisons
were few, no correction for multiplicity of tests was performed.
RESULTS
The rostro-caudal extent of the FluoroGold deposit in each of
the 17 rats with a regionally specific injection is presented in
Table 2 and examples of these injections are shown in Figure 1. In
general, the injection sites and surrounding penumbrae extended
less than 1 mm medio-laterally and less than 750 µm dorso-
ventrally.
FluoroGold-filled perikarya were observed in the caudal VNC
of all 17 rats with tracer injections restricted to RVLM or
CVLM. As previously observed (Holstein et al., 2011), most
of the retrogradely-filled vestibular cells were located in the
TABLE 2 | FluoroGold injection sites.
Caudal Center Rostral
RVLM
R600 −12.60 −12.30 −12.00
R601 −12.24 −12.12 −12.00
R647 −12.60 −12.36 −12.00
R669 −12.78 −12.48 −11.80
R652 −12.80 −12.40 −11.88
R687 −12.28 −11.90 −11.78
R696 −12.57 −12.11 −11.88
R698 −12.66 −12.43 −12.12
R700 −12.60 −12.36 −12.18
R701A −12.84 −12.36 −12.12
CVLM
R609 −13.65 −13.08 −12.80
R688 −13.66 −13.41 −13.16
R690 −13.68 −13.43 −12.93
R695 −13.56 −13.22 −12.30
R697 −13.44 −13.20 −12.96
R702 −13.68 −12.96 −12.80
R709 −13.60 −13.44 −12.96
Legend: Approximate Bregma levels of the tracer injection site (Center) and the
rostral and caudal extent of the diffusion penumbra in RVLM or CVLM of all rats
used for the multiple label immunofluorescence studies of cFos- and FluoroGold-
positive neurons.
caudal half of SpVN, MVN and MVNpc. These cells, which
had fusiform, multipolar, or small globular perikarya, were
interpreted as vestibular neurons with direct projections to the
injected region.
Selected vibratome sections through the caudal vestibular
nuclei were processed for immunofluorescence detection of
FluoroGold and glutamate. The low-affinity monoclonal anti-
glutamate antibody used in this study was described in detail
previously (Holstein et al., 2004, 2011). While some neurons
had barely detectable immunofluorescence signal, a subset of
neurons were intensely immunofluorescent. Only these latter
cells were designated as glutamate-immunofluorescent neurons
in the present study. All three cytological types of neurons
in the caudal vestibular nuclei that were previously identified
by retrograde tracing alone (multipolar neurons, fusiform
neurons and small globular neurons) displayed co-localization
of FluoroGold and glutamate immunofluorescence (Figure 2).
Thus, aside from the larger diameters of most SpVN cells,
there were no differences in the cytology of double-labeled
FluoroGold and glutamate-immunofluorescent neurons in
different vestibular regions (SpVN, MVN or MVNpc), in those
projecting to RVLM vs. CVLM, or in the double-labeled
neurons projecting to the ipsilateral vs. contralateral ventrolateral
medulla.
To support our hypothesis that the glutamate
immunofluorescent neurons utilize this amino acid for
neurotransmission, brainstem sections from three rats with
anterograde Pha-L injections in the caudal vestibular nuclei were
immunolabeled with antibodies to the three vesicular glutamate
transporters (VGluTs), which are thought to be highly specific
for glutamatergic neurotransmission (Fremeau et al., 2004;
El Mestikawy et al., 2011). We did not observe co-localization of
Frontiers in Neuroanatomy | www.frontiersin.org 6 February 2016 | Volume 10 | Article 7
Holstein et al. Glutamate and GABA in Vestibulo-Sympathetic Pathway Neurons
FIGURE 1 | Photomicrographs of immunoperoxidase/DAB-stained Vibratome sections from four rats, two with FluoroGold tracer injections in RVLM
(A,B) and two with tracer injections in CVLM (C,D). Bregma levels were estimated by matching anatomical boundaries with a stereotaxic atlas (Paxinos and
Watson, 2009 #2695). Scale bar in lower right: 1 mm for all panels.
VGluT-1 or VGluT-3 in Pha-L-filled axons in RVLM or CVLM.
However, many of the Pha-L labeled vestibular processes and
terminals in RVLM and CVLM co-localized VGluT-2 (Figure 3),
supporting the observations obtained using anti-glutamate
immunolabeling, suggesting that a portion of the VSR pathway
is glutamatergic.
To confirm the putative role of FluoroGold-labeled vestibular
neurons in mediating the VSR, low frequency binaural sGVS
was used to stimulate vestibular nerve fibers in all rats
prior to perfusion. Activation of neurons in the vestibular
nuclei was assessed by immunofluorescence detection of c-
Fos protein. Some tissue sections from these animals were
immunostained concomitantly for c-Fos, FluoroGold, and
glutamate, in order to localize the amino acid in cells that
were both activated by vestibular stimulation and had direct
projections to one of the target regions (RVLM or CVLM).
We refer to such cells as ‘‘activated projection neurons’’ of
the VSR. Many of the sGVS-activated vestibular neurons
with projections to either CVLM or RVLM were glutamate-
immunofluorescent. Triple-labeled cells were present in both
SpVN and MVN, and all three cytologic types were observed
(Figure 4).
Unexpectedly, we also found that some activated
projection neurons in MVN and SpVN were intensely GABA-
immunofluorescent (Figure 5). Aside from neurotransmitter
content, the GABA-immunofluorescent activated projection
neurons were indistinguishable cytologically from the
glutamate immunofluorescent subpopulation. However, GABA-
immunofluorescent processes and puncta were usually observed
adjacent to the GABAergic activated projection neurons,
suggesting substantial inhibitory input to these GABAergic VSR
neurons.
Quantitative Estimates of Glutamate- and
GABA-Immunofluorescent VSR Neurons
As described above, representative tissue sections through
the caudal vestibular nuclei of each rat with a unilateral
FluoroGold tracer injection restricted to RVLM or CVLM
were immunolabeled to visualize the tracer, cFos protein,
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FIGURE 2 | Examples (long arrows) of intensely glutamate immunofluorescent neurons (red) in the caudal vestibular nuclei retrogradely-filled (green)
following FluoroGold tracer injections in the ventrolateral medulla. DAPI (blue) was used to visualize the location and approximate size range of cell nuclei.
(A) Two neurons in caudal MVN, a small globular neuron above, and a fusiform cell below. Both neurons projected to contralateral RVLM. (B) A small globular neuron
and a larger multipolar neuron in SpVN, both glutamate immunofluorescent and retrogradely filled with FluoroGold, projecting to ipsilateral RVLM. Shorter arrows
point to three additional glutamate immunofluorescent and FluoroGold-filled neurons in the field. (C) Three FluoroGold-labeled glutamate immunofluorescent neurons
in SpVN with direct projections to contralateral RVLM. (D) A glutamate immunofluorescent and FluoroGold-filled fusiform neuron in SpVN with terminals in
contralateral RVLM. (E) A small glutamate immunofluorescent and FluoroGold-immunolabeled globular neuron in SpVN projecting to contralateral CVLM. All scale
bars: 20 µm.
and either glutamate or GABA. These data were used to
obtain quantitative estimates of the relative frequencies
of different subpopulations of glutamate- and GABA-
immunofluorescent activated projection neurons. However,
since glutamate and GABA were not co-localized in
individual tissue sections (see ‘‘Materials and Methods’’
Section), and it is possible that some neurons could
utilize both amino acids for neurotransmission, the data
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FIGURE 3 | Vesicular glutamate transporter 2 (VGluT2) in vestibular processes and terminals in the RVLM. The vestibular axons were identified by
anterograde Pha-L tracer injection in SpVN. Some PhaL-immunofluorescent vestibular processes and puncta (red) co-localize VGluT-2 (green). Some examples are
encircled. Scale bar: 20 µm.
were not appropriate for estimating the total numerical
populations of GABA- and glutamate-immunofluorescent VSR
neurons.
Glutamate-Immunofluorescent VSR
Neurons Projecting to RVLM
One hundred twelve FluoroGold and cFos double-labeled
vestibular neurons were examined in tissue sections further
stained for glutamate immunofluorescence from rats with
tracer injections in RVLM. Of the 112 cFos- and FluoroGold-
positive neurons, 93 (83%) were glutamate-immunofluorescent
(Table 3A). These triple-labeled neurons were more prevalent
in SpVN than in MVN (57% vs. 43% of the total population
of glutamate-immunofluorescent cells with direct projections to
RVLM). Although glutamate-immunofluorescent VSR neurons
projected to contralateral as well as ipsilateral RVLM, cells
with ipsilateral projections were significantly more numerous
(64% vs. 36%, respectively; p = 0.0007). Of the total population
of glutamate-immunofluorescent VSR neurons projecting to
RVLM, the largest cluster of cells was located in SpVN and
projected ipsilaterally, the smallest subpopulation was located in
SpVN and projected contralaterally, and the projections from
MVN to ipsilateral and contralateral RVLM had intermediate
values. Thus, while glutamate-immunofluorescent cells with
direct projections to RVLM arise from both SpVN and MVN,
and issue both ipsilateral and contralateral projections, the
input to RVLM from ipsilateral SpVN is more than double
that from the contralateral SpVN. In contrast, there is no
statistically significant laterality predominance in the glutamate-
immunofluorescent projections fromMVN to RVLM.
Glutamate-Immunofluorescent VSR
Neurons Projecting to CVLM
Seventy four FluoroGold and cFos double-labeled somata
with direct projections to CVLM were observed in tissue
sections through the caudal vestibular nuclei that were
also immunostained for glutamate (Table 3B). Of these,
62 (84%) were triple-labeled. As with the RVLM-projecting
neurons, glutamate-immunofluorescent VSR neurons projecting
to CVLM were found in caudal SpVN and MVN, but were
significantly more numerous in SpVN (76% vs. 24%; p < 0.0001)
and more prevalent on the side ipsilateral to the tracer injection
(66%; p = 0.01).
GABA-Immunofluorescent VSR Neurons
Projecting to RVLM and CVLM
As illustrated above, some activated projection neurons were
GABA-immunofluorescent. The overwhelming majority of these
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FIGURE 4 | Vibratome sections stained concomitantly for glutamate (red), FluoroGold (green) and cFos (blue) following tracer injections in the
ventrolateral medulla and subsequent activation of the vestibulo-sympathetic reflex (VSR) using sinusoidally modulated GVS (sGVS). Each large panel
illustrates two activated projection neurons (arrows) with glutamate immunofluorescence in a merged image; the smaller panels to the right are the single channel
images. (A) SpVN neurons with projections to contralateral RVLM. (B) MVN cells with projections to contralateral CVLM. (C) MVN neurons with projections to
ipsilateral CVLM. Color key in (A) is for all panels. Scale bars in (A–C): 10 µm.
(80%) projected to CVLM (Table 4). In addition, although
they were present in both SpVN and MVN, over 40% were
observed in SpVN and had ipsilateral projections (p = 0.02;
Table 4B).
Overall, these data demonstrate that glutamate
immunofluorescent VSR neurons projecting to RVLM or
CVLM are present in SpVN and MVN and as a population,
give rise to both ipsilateral and contralateral pathways.
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FIGURE 5 | FluoroGold-filled (green), sGVS-activated (cFos; blue) GABA-immunofluorescent (red) vestibular neurons. (A) SpVN neuron with ipsilateral
projections to CVLM. (B–D) MVN neurons with projections to contralateral CVLM. Each panel contains a central merged image with the three single channel images
surrounding it. GABA-immunofluorescent processes and puncta were often observed adjacent to the GABA-immunofluorescent activated projection neurons
(A,B,D). Color key in (D) is for all panels. Scale bars in all panels: 10 µm.
In addition, there is a GABAergic VSR projection, also
arising from both SpVN and MVN, that is almost exclusively
directed to CVLM. These projections are summarized in
Figure 6.
The Rostro-Caudal Distribution of
Glutamate- and GABA-Immunofluorescent
VSR Neurons
The approximate Bregma level of each stained Vibratome section
was identified based on landmark structures in the sections
compared to a rat stereotaxic atlas (Paxinos and Watson, 2009).
The sections, which extended overall from Bregma −13.30
to −10.45, were then binned into 10 representative levels:
−13.08 (sections between−13.30 and−12.97),−12.84 (sections
between −12.96 and −12.73), −12.60 (sections between −12.72
and −12.49), −12.36 (sections between −12.48 and −12.25),
−12.12 (sections between−12.24 and−12.01),−11.88 (sections
between −12.00 and −11.77), −11.64 (sections between −11.76
and −11.53), −11.40 (sections between −11.52 and −11.29).
−11.16 (sections between −11.28 and −10.99) and −10.8
(sections between −10.98 and −10.45). The cells were mapped,
distinguishing ipsilateral from contralateral projections to RVLM
and CVLM, with the simplifying assumption that all activated
projection neurons had exclusively ipsilateral or contralateral
projections.
Glutamate-immunofluorescent activated projection neurons
were observed throughout all but the caudal-most pole of
the vestibular nuclear complex (Figure 7). Both ipsilaterally-
and contralaterally-projecting cells were found from Bregma
−12.96 through −10.54. However, cells with direct projections
TABLE 3 | Glutamate-immunofluorescent activated projection neurons in
the caudal vestibular nuclei.
Ipsilateral Contralateral All
(%) (%) (%)
(A) Cells projecting to RVLM (N = 93)
MVN 24 19 43
SpVN 40∗∗ 17∗∗ 57
Total 64∗ 36∗ 100
(B) Cells projecting to CVLM (N = 62)
MVN 18 6.50 24∗∗∗
SpVN 48 27.50 76∗∗∗
Total 66∗∗∗∗ 34∗∗∗∗ 100
Notes: ∗Significant difference by chisquare analysis, p = 0.0007; ∗∗Significant
difference by chisquare analysis, p = 0.004; ∗∗∗Significant difference by chisquare
analysis, p < 0.0001; ∗∗∗∗Significant difference by chisquare analysis, p = 0.01.
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FIGURE 6 | Summary schematic diagram of the patterns of glutamate immunofluorescent (A) and GABA-immunofluorescent (B) sGVS-activated
vestibular neurons with projections to RVLM and CVLM. In this summary, the percentages of activated projection neurons in each of the four source regions
(ipsilateral and contralateral SpVN and MVN) are calculated separately for projections to RVLM and to CVLM (The 99% total for glutamate-positive projections to
CVLM is rounding error). Data for the triple-labeled GABA cells were obtained from eight rats; data for the triple-labeled glutamate-immunofluorescent cells were
obtained from 12 rats. The line thickness reflects the relative proportion of those percentages. Dashed lines, which also lack percentage estimates, indicate the
extremely small GABAergic projection to RVLM. This schematic highlights the putatively excitatory projection to ipsilateral RVLM and putatively inhibitory projections
to ipsilateral and contralateral CVLM from the caudal vestibular nuclei.
to the ipsilateral RVLM were concentrated in two regions:
SpVN at approximately Bregma −11.88 and parvocellular MVN
near Bregma−11.16. In contrast, glutamate-immunofluorescent
VSR neurons projecting to ipsilateral CVLM were concentrated
TABLE 4 | GABA-immunofluorescent activated projection neurons in the
caudal vestibular nuclei.
Ipsilateral Contralateral All
(A) Cells projecting to RVLM (N = 10)
MVN 2 0
SpVN 7 1
(B) Cells projecting to CVLM (N = 39)
MVN 13%∗ 28%∗ 41%
SpVN 41%∗∗ 18%∗∗ 59%
Total 54% 46% 100%
∗Significant difference by chisquare analysis, p = 0.02; ∗∗Significant difference by
chisquare analysis, p = 0.02.
more caudally, near Bregma −12.12. Similarly, cells projecting
to contralateral RVLM were widely dispersed through the
caudal vestibular nuclear region, whereas those projecting to
contralateral CVLM were concentrated caudally, and primarily
in SpVN.
GABAergic activated projection neurons were observed from
Bregma −13.18 to −10.94 (Figure 8). Most of these neurons
projected from SpVN to the ipsilateral CVLM and these cells
were most highly concentrated near Bregma−11.88.
DISCUSSION
Glutamate and GABA in Central Vestibular
Neurons
This study found intense glutamate immunofluorescence in
vestibular neurons that are activated by sGVS and project
to presympathetic regions of the ventrolateral medulla. Since
glutamate is present in the cytoplasm of all neurons as part
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FIGURE 7 | Location of glutamate immunofluorescent vestibular neurons that were activated by sGVS and had direct projections to the ipsilateral
(filled circles on left side of each drawing) or contralateral (Xs on right side of each drawing) RVLM (green) or CVLM (magenta). There were two high
density clusters of glutamate immunofluorescent activated projection neurons, one located at Bregma −11.16 and one at Bregma −11.88. The highest overall
density of glutamate immunofluorescent activated vestibular neurons with projections to CVLM was observed at Bregma −12.12. The individual drawings are based
on Paxinos and Watson (2005). Abbreviations not used in the text previously: 12 N, hypoglossal nucleus; ICP, inferior cerebellar peduncle; LVN, lateral vestibular
nucleus; MLF, medial longitudinal fasciculus; MVNmc: magnocellular region of MVN; MVNpc, parvocellular region of MVN; NTS, solitary nucleus; PPH, prepositus
nucleus; SCP, superior cerebellar peduncle; sp5, spinal trigeminal tract; Sp5, spinal trigeminal nucleus; SVN, superior vestibular nucleus.
of the metabolic store of amino acids, these observations
do not definitively identify glutamate as a neurotransmitter
of the VSR. To supplement the findings obtained using
the low affinity anti-glutamate antibody, three glutamate
transporters (VGluT1–3) were localized in sections through the
ventrolateral medulla containing anterogradely-filled vestibular
axons and terminals. These studies demonstrated co-localization
of VGluT-2, but not VGluT-1 or -3, in vestibular processes and
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FIGURE 8 | Location of GABA-immunofluorescent vestibular neurons that were activated by sGVS and had direct projections to the ipsilateral (filled
circles on left side of each drawing) or contralateral (Xs on right side of each drawing) RVLM (aqua) or CVLM (orange). The highest overall density of
these cells was observed at Bregma −11.88. The preponderance of GABA-IMF activated vestibular neurons project to CVLM, not RVLM. The individual drawings are
based on Paxinos and Watson (2005). Abbreviations as in Figure 7.
endings in the RVLM and CVLM, supporting the proposition
that many vestibulo-sympathetic pathway neurons utilize
glutamate for neurotransmission. However, since VGluT-2
has been identified in medullary neurons that manifest
a non-glutamatergic phenotype, and since there is a lack
of correspondence between glutamate and VGluT mRNA-
containing somata in this region (Stornetta et al., 2002a,b;
Llewellyn-Smith et al., 2007), the presence of the VGLUT-2
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glutamate transporter in vestibular terminals must also be
interpreted conservatively. Thus, our data suggest, but do not
definitively demonstrate, that some portion of the VSR is
glutamatergic.
Transmitter levels of glutamate or aspartate have previously
been described in all four main vestibular nuclei (Kevetter et al.,
2000; Holstein, 2012; Vidal et al., 2015) and have been associated
with several different vestibular effector pathways (Highstein
and Holstein, 2006). Subregions of the vestibular nuclei send
glutamatergic projections to contralateral abducens motor and
internuclear neurons, mediating the excitatory limb of the
horizontal vestibulo-ocular reflex. Similarly, central vestibular
neurons of the vertical vestibulo-ocular reflex send glutamatergic
projections to the contralateral trochlear and oculomotor cell
groups and at least a portion of the lateral vestibulo-spinal
tract, which conveys otolith signals to the extensor motor
neurons of the spinal cord, utilizes glutamate (Kevetter and
Coffey, 1991; Du Beau et al., 2012). Some vestibulo-cerebellar
projections are glutamatergic, as are the excitatory fibers of the
vestibular commissural system, which is important for bilateral
vestibulo-ocular control. Thus, glutamate neurotransmission
is widespread in the central vestibular nuclei, and would
not in itself serve as a unique identifier of VSR pathway
neurons.
This study also found that a small component of the VSR
pathway is GABAergic. Like glutamate, however, GABA is
not exclusively found in vestibular neurons with autonomic
projections (Popratiloff and Peusner, 2011). GABAergic neurons
in various parts of the vestibular nuclear complex send
projections to oculomotor neuron pools, participate inmediating
commissural inhibition (Holstein et al., 1999a; Straka and
Dieringer, 2000), contribute to vestibulo-olivary (Barmack and
Yakhnitsa, 2013) and vestibulo-spinal (Blessing et al., 1987)
tracts, and may also comprise a population of local circuit
neurons (Grassi et al., 1995; Holstein et al., 1999b). Although
the GABAergic component of the VSR pathway appears to arise
from a relatively small group of vestibular neurons, our previous
studies have demonstrated that the VSR axons in RVLM and
CVLM are highly branched and laden with varicosities (Holstein
et al., 2011). These two structural features suggest that each of
the GABAergic, as well as glutamatergic VSR neurons exerts
widespread influence over large areas of the target nuclei.
The diverse functional roles of glutamate and
GABA in vestibular effector pathways are supported by
electrophysiological and biochemical studies that have provided
direct evidence for GABAergic (Bagnall et al., 2007) and
glutamatergic (Broussard, 2009) neurotransmission in the
mouse vestibular nuclei. Moreover, the transmitter phenotypes
of mouse MVN neurons were evaluated using single-cell
expression profiling (Kodama et al., 2012). This latter study,
which identified three excitatory and three inhibitory cell
types (E1–3 and I1–3, respectively), was restricted to a
portion of MVN located rostral to many of the vestibulo-
sympathetic neurons, particularly those with projections to
CVLM, and included both magnocellular and parvocellular
MVN regions. The E1 and E2 groups of this study were both
glutamatergic; E1 is thought to comprise vestibulo-ocular
neurons with projections to contralateral oculomotor nuclei
and E2 cells projecting primarily to cerebellar cortex. The
role(s) of E3 glutamatergic cells were not identified, but
the authors speculated that these cells may contribute to
vestibulo-autonomic circuitry. Based on the topography of our
glutamate-immunofluorescent activated projection neurons,
it is likely that at least some of the more caudally located E3
cells are VSR pathway neurons. Among the inhibitory cells,
the I1 group was predominantly glycinergic, and the I2 cells
gave rise to the ipsilateral projection to the abducens nucleus
(Spencer and Baker, 1992). Most cells in the I3 group of
inhibitory neurons were interpreted as GABAergic, perhaps
participating in the inhibitory component of the vestibular
commissure. Based on the present findings, a portion of this
I3 cell group may comprise the GABAergic cells of the VSR
pathway.
Cytology of Glutamate and
GABA-Immunofluorescent
Vestibulo-Sympathetic Neurons
Our previous studies have identified three cell types that send
direct projections to the ventrolateral medulla. These include (a)
multipolar neurons with 3–5 dendrites radiating from the soma,
and cell bodies of 25–35 µm in equatorial diameter; (b) smaller
spherical neurons approximately 10–15 µm in diameter, with
fewer dendritic processes; and (c) spindle-shaped neurons with
dendrites emanating from each pole of the cell body (Holstein
et al., 2014). All three cell types were observed in the present
study as well, and there was no correlation between the cytology
of the neuron and its amino acid content, location in SpVN vs.
MVN, terminal field in RVLM vs. CVLM, or laterality of the
projection. However, none of the vestibulo-autonomic neurons
were of the larger diameters characteristic of vestibulo-ocular and
vestibulo-spinal cells. Thus, while GABAergic and glutamate-
immunofluorescent vestibulo-sympathetic neurons cannot be
distinguished from each other on the basis of cytology, they are
markedly different in overall size from the majority of vestibular
neurons.
Regional Localization of Glutamate and
GABA-Immunofluorescent
Vestibulo-Sympathetic Neurons
Overall, vestibulo-sympathetic activated projection neurons were
observed in caudal MVN, parvocellular MVN and the caudal
half of SpVN. The glutamate-immunofluorescent activated
projection neurons were present in both SpVN and caudal
MVN, with the population of cells projecting to RVLM
located slightly more rostrally than those projecting to CVLM.
In contrast, the majority of GABA-immunofluorescent cells
projecting to the ventrolateral medulla were concentrated in
SpVN, and sent ipsilateral projections to CVLM. Since the
neurons in this study were identified in part using sGVS
activation, and sGVS primarily activates otolith afferents (Ray
et al., 1998; Watson et al., 1998; Lau et al., 2003; Bent
et al., 2006; Cohen et al., 2011b), it is not surprising that the
distributions of VSR neurons identified in this study correspond
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well with otolith nerve projection patterns, which primarily
target SpVN and caudal MVN (Dickman and Angelaki, 2002;
Straka et al., 2002; Newlands and Perachio, 2003; reviews:
Barmack, 2006; Angelaki and Cullen, 2008). Similarly, the
suggestion of a topographic organization in the VSR cells
may reflect a more general topographic organization in the
vestibular nuclei. At least in MVN, the larger neurons in the
magnocellular region receive afferents from the semicircular
canals and the flocculus, send projections to the extraocular
motor nuclei, and are functionally related to the vestibulo-
ocular reflex, whereas neurons in the caudal and parvocellular
regions tend to be smaller, receive inputs from the otolith
organs, spinal cord, nodulus, uvula and possibly the fastigial
nucleus, and send efferents primarily to the inferior olive,
cerebellum, ventrolateral medulla, and spinal cord (Büttner-
Ennever and Gerrits, 2004). It remains to be determined,
however, whether vestibular neurons projecting to RVLM
and/or CVLM are segregated from or intermingled with those
projecting to other autonomic medullary regions such as the
solitary nucleus and the dorsal motor vagal nucleus that are
important for cardiac and gastrointestinal functions (Balaban
and Beryozkin, 1994; Yates et al., 1994, 2014b; Ruggiero et al.,
1996).
Functional Significance
When humans rise from a supine position, or quadrupeds
rear or climb, there is a caudal shift in blood and other body
fluids. As blood pools in the leg vasculature, there is decreased
venous return to the heart, which reduces cardiac output and
blood pressure. Concomitantly, because of the change in body
orientation, the force of gravity exerts a greater impact on the
fluids in the lower body, requiring higher blood pressure to
overcome that force than would be required if the body was
horizontal (Hall, 2016). Blood redistribution due to a postural
change is initially triggered by the VSR pathways from the caudal
vestibular nuclei to presympathetic regions of the medulla,
including the RVLM and CVLM (Yavorcik et al., 2009). In
general, these pathways assure that postural adjustments do not
cause marked fluctuations in cerebral perfusion, which would
deprive the brain of a consistent supply of oxygen and glucose.
Subsequent to the activation of sympathetic nerve activity by the
VSR, the baro- and cardiopulmonary reflexes re-establish and
maintain homeostatic blood pressure control (Yates and Miller,
1994; Yates and Bronstein, 2005).
Activation of the VSR pathway in experimental animals has
been achieved using a variety of physiological (Doba and Reis,
1974; Yates and Miller, 1994; Woodring et al., 1997; Jian et al.,
1999; Mori et al., 2005; Wilson et al., 2006; Abe et al., 2007,
2008a; Yavorcik et al., 2009) and electrical (Cobbold et al.,
1968; Uchino et al., 1970; Steinbacher and Yates, 1996; Kerman
and Yates, 1998; Kerman et al., 2000a,b; Yates et al., 2000;
Kasumacic et al., 2012) stimuli ranging from linear acceleration
and centrifugation to electrical stimulation of the vestibular
labyrinth or nerve. The resultant VSR-related activity has been
assessed using measurements of physiological parameters such
as blood pressure and heart rate, as well as recordings of
FIGURE 9 | One example of the hodology supported by the present
data. Differential activation of component parts of the pathway could result in
either increased or decreased blood pressure. See text for details.
sympathetic nerve activity associated with innervation of target
tissues such as vascular smooth muscle and skin. Overall,
these studies have demonstrated increased, decreased, and/or
biphasic sympathetic responses to vestibular stimulation (Bolton
et al., 2004; Gotoh et al., 2004; Abe et al., 2008b) leading
to the summary conclusion that the role of the VSR is
modulatory and complex (Yates et al., 2014a). While the
results of the present study support this overall conclusion, the
existence of GABAergic as well as putatively glutamatergic VSR
projections may provide an additional/alternative explanation
for the variability observed in response outcome following
VSR activation. Conceivably, the magnitude and direction
of blood pressure changes mediated by the VSR reflect the
relative activation of two pathways—an excitatory projection
to RVLM that utilizes glutamate and an inhibitory projection
to CVLM that utilizes GABA. The latter cells, in turn, may
activate excitatory and/or inhibitory neurons in CVLM that
project to RVLM, adding further possible flexibility in the blood
pressure responses to otolith activation (Figure 9). In its simplest
configuration, contemporaneous stimulation of the glutamate
VSR pathway to RVLM and the GABA VSR projection to
GABAergic neurons in CVLM would result in activation of the
maximal percentage of presympathetic neurons in the RVLM,
resulting in a maximal VSR-induced increase in blood pressure.
In contrast, predominant activation of only one of the two
pathway components would diminish or even reverse this effect
on blood pressure. Further subtleties in blood pressure changes
could result from differential activation of the synergist parallel
pathways, depicted in Figure 6 but not Figure 9. Additional
studies will be needed to identify the specific roles of these two
facets of the VSR.
Methodological Considerations and Study
Limitations
1. The quantitative estimates are based on triple-labeled
cells only. To be included in the cell counts, individual
neurons needed to display specific immunofluoresence signal for
FluoroGold, cFos and one of the two amino acids examined in
this study. Since these staining protocols may fail to triple-stain
all relevant cells, and since imunofluorescence sensitivity is lower
than that of immunohistochemistry, the cell counts obtained
in this study are undoubtedly underestimates of the total
populations. Furthermore, we observed much larger populations
of double-labeled GABA and glutamate stained cells (e.g., cFos
and GABA or FluoroGold and GABA immunofluorescent, but
not cFos-, FluoroGold- and GABA-labeled) that were excluded
from the study, although some of these cells may well be VSR
neurons. For these reasons, the counts are likely to understate
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the real size of the total populations, although the relative
proportions of the subpopulations are likely to stay the same.
2. Multiple additional neurotransmitters and modulators
are thought to be present in VNC neurons. For example,
immunolabeling and expression profiling studies suggest
that some GABA- and glutamate-containing VNC neurons
co-express glycine (Tanaka and Ezure, 2004; Lu et al.,
2008; Popratiloff and Peusner, 2011; Kodama et al., 2012).
However, the present study focused exclusively on the
localization of glutamate and GABA in activated projection
neurons of the VSR and did not include a more extensive
assessment of the complete neurochemical phenotype of these
cells.
3. Isoflurane inhalation anesthesia was used for all
experiments of the present study. There is some evidence
that c-fos gene expression is affected by general anesthetics,
increasing gene activity in autonomic nuclei (Takayama et al.,
1994; Hamaya et al., 2000; Roda et al., 2004). However, it appears
that different anesthetics and different routes of administration
impact c-fos gene activation and subsequent protein expression
variably. Particularly pertinent to the present study, decreases in
blood pressure, often observed with sGVS, can be accompanied
by increased numbers of cFos-immunolabeled neurons in
appropriate brainstem regions. Moreover, the number of cFos-
positive neurons in limbic areas of the brainstem and cerebral
cortex are no different in isoflurane anesthetized (3% induction,
2% maintenance) and unanesthetized rats (Kufahl et al., 2009).
In addition, while c-fos mRNA expression in rat brain is
significantly higher than baseline after 30 min of exposure to
2% isoflurane, the expression level returns to baseline within
60 min, even when the anesthesia is continued for a total of
2 h (Hamaya et al., 2000). Thus, isoflurane does not appear to
alter c-fos gene transcription or depress c-fos mRNA expression.
Based on these reports, and our observations in sGVS control rats
(Holstein et al., 2012), it is unlikely that the cFos immunolabeling
observed in the present study is attributable to the isoflurane
anesthesia.
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